HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Schirbel Selected Research

Adenoma (Adenomas)

11/2023Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism.
1/2021Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations.
1/2018Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Schirbel Research Topics

Disease

38Neoplasms (Cancer)
12/2023 - 06/2008
14Neoplasm Metastasis (Metastasis)
02/2024 - 06/2008
13Adrenocortical Carcinoma
02/2024 - 03/2012
9Prostatic Neoplasms (Prostate Cancer)
10/2023 - 06/2015
9Multiple Myeloma
01/2023 - 04/2015
6Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 10/2019
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2023 - 02/2016
4Adrenocortical Adenoma (Disease, Conn's)
11/2022 - 06/2008
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 01/2014
3Hyperaldosteronism (Conn Syndrome)
11/2023 - 01/2019
3Adenoma (Adenomas)
11/2023 - 01/2018
3Lymphoma (Lymphomas)
10/2022 - 11/2018
3Sarcoidosis (Schaumann Disease)
01/2018 - 11/2016
2Squamous Cell Carcinoma of Head and Neck
01/2023 - 11/2021
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 01/2019
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2022 - 10/2022
2Pheochromocytoma
11/2022 - 06/2022
2Inflammation (Inflammations)
01/2020 - 11/2016
2Adenocarcinoma
01/2019 - 06/2008
2Leukemia
01/2019 - 01/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Tumor Lysis Syndrome
01/2023
1Renal Insufficiency (Renal Failure)
01/2023
1Hypersensitivity (Allergy)
01/2023
1Paraganglioma (Paragangliomas)
11/2022
1Adrenal incidentaloma
11/2022
1Adrenal Gland Diseases
11/2022
1Primary Myelofibrosis (Myelosclerosis)
01/2022
1Paraproteinemias (Monoclonal Gammopathy)
01/2022
1Polycythemia Vera
01/2022
1Essential Thrombocythemia
01/2022
1Adrenal Gland Neoplasms (Adrenal Cancer)
12/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021
1Pituitary Neoplasms (Pituitary Adenoma)
01/2021
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021
1Cushing Syndrome
01/2021
1Smoldering Multiple Myeloma
08/2020
1Meningioma (Meningiomas)
05/2020
1Atherosclerotic Plaque (Atheroma)
01/2020
1Atherosclerosis
01/2020
1Acoustic Neuroma (Acoustic Neurinoma)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Sepsis (Septicemia)
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019

Drug/Important Bio-Agent (IBA)

29Chemokine ReceptorsIBA
02/2024 - 04/2015
2368Ga-pentixaforIBA
12/2023 - 01/2016
8Radioisotopes (Radionuclides)IBA
01/2021 - 03/2012
7AntigensIBA
02/2024 - 06/2015
7Somatostatin Receptors (Somatostatin Receptor)IBA
04/2023 - 04/2014
7Peptide Receptors (Peptide Receptor)IBA
01/2021 - 01/2014
6Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2009
5LigandsIBA
10/2022 - 02/2016
4Biomarkers (Surrogate Marker)IBA
11/2022 - 05/2020
4Edotreotide (SMT 487)IBA
11/2022 - 04/2014
4iodophenyl metomidateIBA
12/2021 - 06/2008
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2021 - 01/2020
4gallium 68 PSMA-11IBA
11/2020 - 06/2015
3PSMA I&TIBA
10/2023 - 01/2022
33-Iodobenzylguanidine (Iobenguane)IBA
11/2022 - 05/2009
3Mitotane (Lysodren)FDA Link
03/2016 - 11/2015
2AldosteroneIBA
11/2023 - 01/2018
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
11/2023 - 01/2018
2CXCR ReceptorsIBA
10/2019 - 01/2018
2LipidsIBA
11/2015 - 09/2015
1RadiopharmaceuticalsIBA
12/2023
1Complement System Proteins (Complement)IBA
12/2023
1EnzymesIBA
11/2023
1N 30IBA
11/2022
1flubrobenguaneIBA
11/2022
1Indicators and Reagents (Reagents)IBA
10/2022
1Dihydroxyphenylalanine (Dopa)IBA
06/2022
1Lutetium-177IBA
01/2022
1PSMA-617IBA
01/2022
1Mixed Function Oxygenases (Monooxygenases)IBA
01/2022
190Y-pentixatherIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Urea (Carbamide)FDA LinkGeneric
01/2022
1Carboxylic AcidsIBA
12/2021
1imidazoleIBA
12/2021
1Peptides (Polypeptides)IBA
11/2021
1CD13 Antigens (Alanine Aminopeptidase)IBA
11/2021
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
11/2021
11- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
11/2021
1CateninsIBA
01/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2021
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2021
1Ubiquitin-Specific ProteasesIBA
01/2021
1AndrogensIBA
11/2020
1Gallium-68IBA
01/2020
168Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE)IBA
01/2020

Therapy/Procedure

25Therapeutics
12/2023 - 03/2012
11Precision Medicine
02/2024 - 01/2017
5Drug Therapy (Chemotherapy)
01/2022 - 02/2016
4Hematopoietic Stem Cell Transplantation
01/2023 - 01/2018
4Radiotherapy
05/2020 - 02/2016
3Castration
10/2023 - 01/2022
3Stem Cell Transplantation
01/2022 - 02/2016
1Lymph Node Excision (Lymph Node Dissection)
11/2021
1Adrenalectomy
01/2021